Article Versions Notes

Laot L, Sonigo C, Nobre J, Benachi A, Dervin T, El Moujahed L, Mayeur A, Stoppa-Lyonnet D, Steffann J, Grynberg M. Should Preimplantation Genetic Testing (PGT) Systematically Be Proposed to BRCA Pathogenic Variant Carriers? Cancers. 2022; 14(23):5769. https://doi.org/10.3390/cancers14235769

Laot, Lucie, Charlotte Sonigo, Julie Nobre, Alexandra Benachi, Traicie Dervin, Lina El Moujahed, Anne Mayeur, Dominique Stoppa-Lyonnet, Julie Steffann, and Michael Grynberg. 2022. "Should Preimplantation Genetic Testing (PGT) Systematically Be Proposed to BRCA Pathogenic Variant Carriers?" Cancers 14, no. 23: 5769. https://doi.org/10.3390/cancers14235769

Laot, L., Sonigo, C., Nobre, J., Benachi, A., Dervin, T., El Moujahed, L., Mayeur, A., Stoppa-Lyonnet, D., Steffann, J., & Grynberg, M. (2022). Should Preimplantation Genetic Testing (PGT) Systematically Be Proposed to BRCA Pathogenic Variant Carriers? Cancers, 14(23), 5769. https://doi.org/10.3390/cancers14235769